Arsia Therapeutics
AcquiredCambridge, United States · Founded 2013 · $1.1M raised
- Headquarters
- Cambridge
- Founded
- 2013
- Business Model
- B2B
- Total Funding
- $1.1M
- Last Round
- $1.0M Series AJun 2015
- Rounds
- 2
- Acquisition Date
- Nov 2016
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
Indexed holds 3 funding rounds and 2 investors for this company. The full record is or through the API.
About
Arsia Therapeutics was an early-stage biotechnology firm founded in 2013 by MIT professors Robert Langer and Alexander Klibanov, together with Polaris Partners, to improve the delivery of highly viscous protein therapeutics. Arsia's proprietary formulation platform enabled subcutaneous administration of high-dose biologics. Headquartered in Kendall Square, Cambridge, Massachusetts, the company was acquired by Eagle Pharmaceuticals in 2016 for up to $78 million.
Summary
Arsia Therapeutics is a Biotech company based in Cambridge, United States, founded in 2013. It has raised $1.1M in total across 2 rounds, most recently a $1.0M Series A round in Jun 2015. Investors include Polaris Partners and Eagle Pharmaceuticals.
Funding & Exit History
Nov 2016
Sign up to see all 3 events
Funding: Seed through Series A. Amounts, valuations, and investors where available.
Investors
Similar Companies
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...
Specialty pharmaceutical company
Altos Labs combines academic science and industry development to create medicines that restore ce...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/arsia-therapeutics"><img src="https://indexed.vc/api/badge/company/arsia-therapeutics" alt="Arsia Therapeutics on Indexed.vc" width="260" height="76" /></a>